北美深蓝 commented on a stock · Oct 4 14:46

🎯Long-term venture capital positions, adding positions 🔥

Finally, after patiently waiting for the main stock and warrants to fall to the additional purchase range, we welcome them again. $NUVATION BIO INC C/WTS 07/07/2027 (TO PUR COM) (NUVB.WS.US)$ 🔴 Finally waited for the simultaneous decline of the underlying stock and warrants, seizing the opportunity to increase holdings, and incrementally adding positions through pending orders.

The company currently holds $0.57 billion, burning less than $30 million on average per quarter. It is expected that by the end of 2025, the company's new drug commercialized products will be launched. Although selling expenses will increase in the pre-listing period, it will also bring corresponding revenue and regional market licensing fees to the company. Once the market expectations are good, the stock price will also enter a golden period, especially in the mainland China market, which is an important explosive factor. At the same time, the company's other drugs in clinical stages are also worth looking forward to!

Pipeline - NUVATION BIO, INC.

Look Forward to Further Advancing Taletrectinib and Plan to Share Results From Global, Pivotal Trust-II Study by End of 2024

The stock warrant will expire in 2027. If everything goes smoothly, it may obtain returns significantly exceeding expectations.

Current data shows, $Nuvation Bio (NUVB.US)$ the capital trend statistics on a daily/weekly/monthly basis are all showing inflow, short positions are less than 7%, and declining.